Galnac-t - OmicsDI

Show results for

Unknown (119)
Proteomics (32)
Transcriptomics (12)
Genomics (6)
Metabolomics (2)

Organisms

Homo sapiens (22)
Andropogon gerardi (17)
Bacteria (17)
Botrytis cinerea (17)
Canis lupus familiaris (17)
Clostridium perfringens (17)
Cnidaria (17)
Cricetulus griseus (17)
Eukaryota (17)
Fasciola (17)
Hepatitis B virus (17)
Human betaherpesvirus 5 (17)
Japanese encephalitis virus group (17)
Madurella mycetomatis (17)
Mesocricetus auratus (17)
Miscanthus x giganteus (17)
Mycobacterium tuberculosis (17)
Orthoflavivirus (17)
Panicum virgatum (17)
Platyhelminthes (17)
Pseudomonas aeruginosa AES-1R (17)
Rickettsia (17)
Saccharomyces cerevisiae (17)
Schizosaccharomyces pombe (17)
Severe acute respiratory syndrome coronavirus 2 (17)
Sorghastrum nutans (17)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (17)
Streptococcus pneumoniae (17)
Mus musculus (3)
Fusarium sinicum (1)

Organisms

Mus musculus (2)
Homo sapiens (1)

Repository

biostudies-arrayexpress (19)
pride (17)
ENA (6)
geo (2)
iProX (2)
jPOST (2)
MassIVE (2)
MetaboLights (1)
MetabolomicsWorkbench (1)

Tissue

Cell culture (4)
Blood serum (2)
Keratinocyte (2)
Skin (2)
Sublingual gland (2)
Feces (1)
Bone (1)
Brain (1)
Breast cancer cell (1)
Cell suspension culture (1)
Colon (1)
Epithelial cell (1)
Heart (1)
Hepatocyte (1)
Kidney (1)
Liver (1)
Lung (1)
Salivary gland (1)
Spleen (1)
Submandibular gland (1)
Whole body (1)

Disease

Hyperphosphatemic familial tumoral calcinosis (3)
Irritable bowel syndrome (1)
Breast cancer (1)
Congenital disorder of glycosylation (1)

Technology Type

Mass Spectrometry (18)
Shotgun proteomics (12)
Bottom-up proteomics (5)
Affinity purification coupled with mass spectrometry proteomics (2)
Data-dependent acquisition (2)
Mass spectrometry assay (1)
ESI (1)
All-ion fragmentation (1)
Data-independent acquisition (1)
Gel-based experiment (1)
SRM/MRM (1)

Instrument Platform

Illumina Truseq RNA Sample Preparation Kit (1)
Illumina HiSeq 2000 (1)
LTQ Orbitrap Elite (1)
ZenoTOF 7600 (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)

Publication Date

2013 (9)
2025 (5)
2023 (5)
2011 (4)
2020 (3)
2015 (2)
2014 (2)
2008 (2)
2026 (2)
2022 (2)
2024 (2)
2019 (2)
2009 (1)
2021 (1)
2018 (1)

Metabolite Name

6-{[2-(2,4-dihydroxyphenyl)-3-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-6-(4-hydroxy-3-methylbut-2-en-1-yl)-4-oxo-4H-chromen-7-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({5,9-dihydroxy-8,8-dimethyl-2-oxo-4-phenyl-2H,8H,9H,10H-pyrano[2,3-h]chromen-10-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid (1)
3-phenyl-1-(2,3,4,6-tetrahydroxyphenyl)prop-2-en-1-one (1)
13-(acetyloxy)-5-hydroxy-9-oxo-8,17-dioxatetracyclo[8.7.0.0,.0,]heptadeca-1(10),2(7),3,5,11,13,15-heptaen-14-yl 2-hydroxyacetate (1)
Nicotinate beta-D-ribonucleotide (1)
Cis-4-Decenoic acid (1)
3,4,5-trihydroxy-6-{[8-(2-hydroxypropan-2-yl)-4-(1-hydroxypropyl)-2-oxo-2H,8H,9H-furo[2,3-h]chromen-5-yl]oxy}oxane-2-carboxylic acid (1)
Cyclic 3-Hydroxymelatonin (1)
4-hydroxy-2H,8H-[1,3]dioxolo[4,5-h]chromen-8-one (1)
4-ACETOXYPHENOL (1)
Alpha-Acetolactate decarboxylase (enzyme preparation from bacillus subtilis recombinant) (1)
3,4,5-trihydroxy-6-[1-(3-phenyloxiran-2-yl)ethoxy]oxane-2-carboxylic acid (1)
3,4,5-trihydroxy-6-{[3-(4-hydroxy-3-methoxyphenyl)-2-oxopropanoyl]oxy}oxane-2-carboxylic acid (1)
[3-(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5,7-dihydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-2-yl)phenyl]oxidanesulfonic acid (1)
[(6-{[5,7-dihydroxy-2-(4-oxocyclohexa-2,5-dien-1-ylidene)-2H-chromen-3-yl]oxy}-3,4-dihydroxy-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)methyl][1-hydroxy-3-(4-hydroxyphenyl)prop-2-en-1-ylidene]oxidanium (1)
9,10-dihydroxy-8,8-dimethyl-2H,8H,9H,10H-pyrano[2,3-h]chromen-2-one (1)
3,4,5-trihydroxy-6-({3-[(7-methoxy-2-oxo-2H-chromen-8-yl)methyl]-2-methyloxiran-2-yl}methoxy)oxane-2-carboxylic acid (1)
Dimoracin (1)
6-{4-[3-(3,5-dihydroxyphenyl)oxiran-2-yl]phenoxy}-3,4,5-trihydroxyoxane-2-carboxylic acid (1)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[2-hydroxy-3-(4-methoxyphenyl)-3-oxo-1-phenylpropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid (1)
3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-5,7-dihydroxy-2-(3-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one (1)
(4-methyl-2-oxochromen-7-yl) acetate (1)
FRAXETIN (1)
[2-hydroxy-5-(2-hydroxy-3-methoxy-3-oxopropyl)phenyl]oxidanesulfonic acid (1)
2',3',4'-Trihydroxyacetophenone (1)
Nicotinamide Adenine Dinucleotide Phosphate (NADP+) (1)
7-[(6-carboxy-3,4,5-trihydroxyoxan-2-yl)oxy]-1-oxo-1H-isochromene-3-carboxylic acid (1)
5'-Adenylyl sulfate (APS) (1)
5-[(E)-2-[6-hydroxy-3-(3-hydroxyphenyl)-2-phenyl-2,3-dihydro-1-benzofuran-5-yl]ethenyl]benzene-1,3-diol (1)
5-hydroxy-3,6,7-trimethoxy-2-(4-methoxyphenyl)chromen-4-one (1)

First Public Date

2026 (1)
2025 (1)
2024 (1)
2023 (1)
2015 (1)
2014 (1)

Study type

Transcription profiling by array (9)
Proteomic profiling by array (9)
RNA-seq of coding RNA (1)

Release Date

2013 (14)
2020 (12)
2017 (10)
2024 (9)
2023 (9)
2019 (9)
2011 (8)
2022 (8)
2021 (7)
2018 (7)
2010 (7)
2015 (6)
2009 (6)
2012 (6)
2016 (5)
2014 (4)
2008 (4)
2025 (3)
2026 (1)
2004 (1)
2003 (1)
2002 (1)

Lab affiliation

Biological Chemistry Section, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland, United States (3)
1. School of Natural Sciences, Macquarie University, Sydney, NSW 2109, Australia 2. Institute for Glyco-core Research (iGCORE), Nagoya University, Nagoya, Japan (1)
Associate Professor Glyco MS Group Copenhagen Center for Glycomics (CCG) Department of Cellular and Molecular Medicine (24.6.36) University of Copenahgen Blegdamsvej 3 2200 Copenhagen N Denmark (1)
Associate Professor Glyco MS Group Copenhagen Center for Glycomics (CCG) Department of Cellular and Molecular Medicine University of Copenahgen Blegdamsvej 3 2200 Copenhagen N Denmark (1)
Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen (1)
Copenhagen Center for Glycomics, University of Copenhagen (1)
Copenhagen Center for Glycomics, University of Copenhagen, Denmark (1)
Department of Biochemistry and Molecular Biology, Drexel University College of Medicine. Translational Cellular Oncology Program, Sidney Kimmel Cancer Center, Thomas Jefferson University (1)
Department of Chemistry, Imperial College London, UK Chemical Glycobiology Laboratory, The Francis Crick Institute, London, UK (1)
Department of Chemistry, Imperial College London, UK; Chemical Glycobiology Laboratory, The Francis Crick Institute, London (1)
Faculty of Health and Medical Sciences Department of Cellular and Molecular Medicine University of Copenhagen (1)
Glyco MS Group Copenhagen Center for Glycomics (CCG) Department of Cellular and Molecular Medicine University of Copenhagen (1)
NIH/NIDCR (1)
University of Copenhagen, Copenhagen Center for Glycomics, GlycoMS group (1)
University of Copenhagen, Department of Cellular and Molecular Medicine (1)

Tags

xref:ArrayExpress:E-MTAB-3844 (1)
xref:PubMed:36002036 (1)
xref:PubMed:17767167 (1)

Previous page
1 / 18
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 18
Next page

Sort by:

Relevance

Page size

Deconstruction of O-glycosylation â€“ Polypeptide GalNAc-T Isoforms Direct Distinct Subsets of the O-Glycoproteome

GalNAc-transferase (GalNAc-T) isoforms modify distinct subsets of the O-glycoproteome and GalNAc-type O-glycosylation is found on most proteins trafficking through the secretory pathway in metazoan cells. The O-glycoproteome is regulated by up to 20 polypeptide GalNAc-Ts and the contributions and bi...

ORGANISM(S): Homo sapiens

2015-09-30 | E-MTAB-3844 | biostudies-arrayexpress

Deconstruction of O-glycosylation â€“ Polypeptide GalNAc-T Isoforms Direct Distinct Subsets of the O-Glycoproteome

PRJEB10772 | ENA

In vivo Mapping of the Mouse Galnt3-specific O-Glycoproteome

The UDP-N-acetylgalactosamine polypeptide:N-acetylgalactosaminyltransferase (GalNAc-T) family of enzymes initiates O-linked glycosylation by catalyzing the addition of the first GalNAc sugar to serine or threonine on proteins destined to be membrane-bound or secreted. Defects in individual isoforms ...

ORGANISM(S): Mus musculus (Mouse)

2025-05-07 | PXD052978 | Pride

Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line

Mucin-type-O-glycosylation on proteins is integrally involved in human health and disease and is coordinated by an enzyme family of 20 N-acetylgalactosaminyltransferases (GalNAc-Ts). Detailed knowledge on the biological effects of site-specific O-glycosylation is limited due to lack of information o...

ORGANISM(S): Homo sapiens (Human)

2022-10-22 | PXD036791 | Pride

Galnt fibronectin ldlr lrp col17a1 Differential glycoproteomics. Crispr 3d tissue models oragnoid

Deconstruction of O-glycosylation--GalNAc-T isoforms direct distinct subsets of the O-glycoproteome.

Not available

S-EPMC4693523 | biostudies-literature

Members of the GalNAc-T family of enzymes utilize distinct Golgi localization mechanisms.

Not available

S-EPMC6192461 | biostudies-literature

The GalNAc-T Activation Pathway (GALA) is not a general mechanism for regulating mucin-type O-glycosylation.

Not available

S-EPMC5515409 | biostudies-literature

TEO-GalNAc: Tag-free Chemoenzymatic Enrichment and Quantitative Mapping of Tn/T Antigen Sialylation Occupancy via Ketone-Oxime Chemistry

TEO-GalNAc is a chemoenzymatic strategy for tag-free enrichment and quantitative mapping of Tn/T O-GalNAc glycopeptides. Ketone-modified CMP-Sia is transferred by ST6GalNAc1 for selective tagging, followed by reversible oxime capture using hydroxylamine beads. Mild acid release enables tag-free reco...

ORGANISM(S): Homo Sapiens

2026-03-04 | PXD075239 |

Polypeptide N-acetylgalactosaminyltransferase (GalNAc-T) isozyme surface charge governs charge substrate preferences to modulate mucin type O-glycosylation.

Not available

S-EPMC10629720 | biostudies-literature

Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line.

Not available

S-EPMC9587226 | biostudies-literature

Previous page
1 / 18
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 18
Next page

Sort by:

Relevance

Page size

171 Results

Show results for

Organisms

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

Metabolite Name

First Public Date

Study type

Release Date

Lab affiliation

Tags

OmicsDI is part of the ELIXIR infrastructure

Tweets